NAD+ - 500mg
Peptides

NAD+ - 500mg

$36.00 $260.00 260 → 36 — Save $224

Nicotinamide adenine dinucleotide (NAD+) is a crucial coenzyme found in all living cells, playing a vital role in various biological processes essential for cellular function and overall health. As a key player in energy metabolism, NAD+ is integral to the conversion of nutrients into usable energy, facilitating critical biochemical reactions within the body. With increasing interest in the fields of health, longevity, and cellular repair, NAD+ supplementation has emerged as a potential therapeutic approach for enhancing well-being and combating age-related decline.

PubChem CID 5892
Molecular Formula C21H27N7O14P2
Molecular Weight 663.4 g/mol
CAS No. 53-84-9
IUPAC Seq. Cond.
Link https://pubchem.ncbi.nlm.nih.gov/compound/5892

Mechanism of Action

NAD+ is primarily known for its role in redox reactions, functioning as a cofactor for enzymes involved in the production of adenosine triphosphate (ATP), the energy currency of cells. By participating in oxidation-reduction reactions, NAD+ is essential for aerobic respiration and mitochondrial function (Yoshino et al., 2018). Furthermore, NAD+ serves as a substrate for sirtuins, a family of proteins that regulate key cellular processes, including stress response, DNA repair, and inflammation. The activation of sirtuins by NAD+ has been linked to various health benefits, including improved metabolic function and enhanced longevity (Mouchiroud et al., 2013).

Moreover, NAD+ plays a significant role in maintaining cellular homeostasis by regulating circadian rhythms and modulating the effects of oxidative stress. As NAD+ levels decline with age, cellular functions may become impaired, contributing to metabolic disorders and age-related diseases (Gomez-Pinilla et al., 2021).

Therapeutic Applications

The therapeutic applications of NAD+ are broad and impactful, particularly in the context of aging and metabolic health. Research has shown that NAD+ levels naturally decrease with age, which may contribute to various age-related conditions, including neurodegeneration, cardiovascular disease, and obesity. Supplementation with NAD+ has been associated with improved mitochondrial function, enhanced physical performance, and better metabolic health in preclinical studies (Yoshino et al., 2018).

In clinical settings, NAD+ administration has shown promise in treating conditions such as substance use disorders, chronic fatigue syndrome, and neurodegenerative diseases. Studies suggest that NAD+ supplementation can lead to improvements in cognitive function, increased energy levels, and a better overall quality of life for individuals suffering from fatigue and other metabolic issues (Gomez-Pinilla et al., 2021).

Safety and Efficacy

NAD+ supplementation is generally well-tolerated, with minimal adverse effects reported in studies. Common side effects may include mild gastrointestinal discomfort, which is typically transient. Its favorable safety profile, combined with its potential health benefits, makes NAD+ an appealing option for individuals looking to enhance their metabolic health and vitality. However, it is recommended that individuals consult healthcare professionals before beginning NAD+ supplementation to ensure it aligns with their health goals.

Conclusion

In summary, NAD+ is a vital coenzyme that plays a critical role in energy metabolism, cellular repair, and overall health. Its involvement in key biological processes makes it an essential component of health and longevity strategies. As research continues to uncover the full potential of NAD+ supplementation, it stands out as a promising option for individuals seeking to optimize their health and enhance their quality of life.

References:

  1. Yoshino, J., et al. (2018). “NAD+ metabolism and its roles in metabolic disorders.” Nature Reviews Endocrinology, 14(4), 198-206.
  2. Mouchiroud, L., et al. (2013). “The NAD+ precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity.” Cell Metabolism, 15(6), 838-847.
  3. Gomez-Pinilla, F., et al. (2021). “NAD+ in the central nervous system: A potential therapeutic target for neurodegenerative diseases.” Frontiers in Neuroscience, 15, 645.
View Cart
Research Use Only. All peptides are for laboratory research purposes only. Not for human consumption. Must be 18+ to purchase.